Autoimmune Inc.

Technion Research & Development Foundation Ltd

Mor Research Applications Ltd.

Rappaport Family Institute for Research in the Medical Sciences

Ariel Miller

Howard L Weiner

Ahmad Al-Sabbagh

David A Hafler

Hossam Haick

Zhengyi Zhang

The present invention provides a system and method for diagnosing, monitoring or prognosing Multiple Sclerosis at different stages as well as affording the prediction of disease activity and response to a treatment regimen, using at least one sensor comprising carbon nanotubes or metal nanoparticles, each coated with various organic coatings in conjunction with a pattern recognition algorithm.

Diagnosing, prognosing and monitoring multiple sclerosis

Described are methods for treating or preventing type I diabetes and insulitis by oral administration of the bystander antigen glucagon. The methods involve oral administration of glucagon in an amounts that are effective to treat or prevent type I diabetes or insulitis.

Bystander suppression of type I diabetes by oral administration of glucagon

Peptides are administered to individuals suffering from multiple sclerosis. The peptides contain immunodominant epitopes of myelin basic protein that are recognized by T-cells from relapsing-remitting multiple sclerosis patients, and that are contained in the 84-102 and 143-168 regions of human MBP.

Suppression of T-cell proliferation using peptide fragments of myelin

Peptides ate provided that are related to immunodominant regions of human MBP.

Growing community of inventors

Haifa, Israel

Ariel Miller